These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9226994

  • 1. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
    Bristow LJ, Kramer MS, Kulagowski J, Patel S, Ragan CI, Seabrook GR.
    Trends Pharmacol Sci; 1997 Jun; 18(6):186-8. PubMed ID: 9226994
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS, Last B, Getson A, Reines SA.
    Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze.
    Cao BJ, Rodgers RJ.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):117-25. PubMed ID: 9369363
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The D2 receptor: love it and leave it.
    Pickar D.
    Mol Psychiatry; 1998 Mar 24; 3(2):101-2. PubMed ID: 9577830
    [No Abstract] [Full Text] [Related]

  • 8. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
    Mamiya T, Matsumura T, Ukai M.
    Ann N Y Acad Sci; 2004 Oct 24; 1025():424-9. PubMed ID: 15542745
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J, Eyrolles L, Bruhwyler J, Delarge J.
    Curr Med Chem; 1998 Apr 24; 5(2):77-100. PubMed ID: 9481035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of selective dopamine D4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats.
    Kawashima N, Okuyama S, Omura T, Chaki S, Tomisawa K.
    Life Sci; 1999 Apr 24; 65(24):2561-71. PubMed ID: 10619364
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition.
    Mansbach RS, Brooks EW, Sanner MA, Zorn SH.
    Psychopharmacology (Berl); 1998 Jan 24; 135(2):194-200. PubMed ID: 9497025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.